EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 -0.4891
March 31, 2026 -3.020
December 31, 2025 -0.7785
September 30, 2025 -1.399
June 30, 2025 -3.063
March 31, 2025 -3.465
December 31, 2024 -2.331
September 30, 2024 -4.170
June 30, 2024 -4.854
March 31, 2024 -3.12
December 31, 2023 -2.726
September 30, 2023 -1.876
June 30, 2023 -0.1399
March 31, 2023 -0.2556
December 31, 2022 -10.40
September 30, 2022 -0.1866
June 30, 2022 -7.474
Date Value
March 31, 2022 -9.597
December 31, 2021 -10.40
September 30, 2021 -10.37
June 30, 2021 -23.85
March 31, 2021 -24.02
December 31, 2020 -15.60
September 30, 2020 -69.40
June 30, 2020 -0.4963
March 31, 2020 -1.149
December 31, 2019 -1.63
September 30, 2019 -0.0085
June 30, 2019 -0.0083
March 31, 2019 -0.2504
December 31, 2018 -150.27
September 30, 2018 29.12
June 30, 2018 -0.0027
March 31, 2018 -45.55

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Numinus Wellness, Inc. -0.0007
Cocrystal Pharma, Inc. -0.2295
Edesa Biotech, Inc. -0.6003
CNBX Pharmaceuticals, Inc. -0.0001
Invion Ltd. --

EPS Diluted (Quarterly) Related Metrics